2025-06-17 – Press Releases – www.prnewswire.com
YANTAI, China, June 17, 2025 /PRNewswire/ — On June 16, 2025, RemeGen Co., Ltd. (“RemeGen”, stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand name: 泰爱®) has received Orphan Drug Designation (ODD) from European Medicines Agency (EMA) for the treatment of…
